|Phase III||Treatment||Completed||70 and over||Other||PHRC, P000502 AOM 98071|
A randomized trial comparing radiotherapy with supportive care in patients aged 70 years or older with newly diagnosed, histologically confirmed anaplastic astrocytoma or glioblastoma, and a Karnofsky performance status > 70.
- Glioblastoma and anaplastic astrocytoma, supratentorial, histologically confirmed
- Brain CT scan or MRI within 28 days before surgery
- Age: 70 years or older
- Karnofsky performance status, 70 or more.
- Life expectancy over 12 weeks
- Informed consent
- Brain radiotherapy
- Severe systemic disease
Trial Lead Organizations/Sponsors
Assistance Publique Hopitaux de Paris
|jean-yves Delattre, MD||Principal Investigator|
|Florence Keime-Guibert, MD||Principal Investigator|
Link to the current ClinicalTrials.gov record.
NLM Identifer NCT00430911
Information obtained from ClinicalTrials.gov on November 20, 2012
Back to Top